Novo Nordisk enters hemophilia gene therapy field

Licencing bluebird bio’s Inc know-how and technology in one-time gene therapies Novo Nordisk A/S tries to get foothold in the emerging hemophilia A gene therapy market.

Read more

Researchers unravel how ADEP antibiotics work

German researchers have unraveled the mechanism of a ADEPs, a novel class of antibiotics, allowing pharmacological optimisation.

Read more

New method allows tracking of HIV

A new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose.

Read more

Rottapharm Biotech: POC in osteoarthritis pain

Rottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis.

Read more

Creoptix AG closes CHF8m financing round

Swiss drug discovery analytics specialist Creoptix AG has raised CHF8m in a Series C financing for commercial expansion.

Read more

AMR: GARDP and Entasis Therapeutics start pivotal study

Entasis Therapeutics Inc (Waltham, USA) and non for profit organisation GARDP (Geneva, Switzerland) have initiated Phase III testing of the novel antibiotic zoliflodacin to treat infections with the WHO priority pathogen N. gonorrhoea.

Read more

BASF broadens biotech business by Isobionics acquisition

BASF SE has strengthened its capabilities in recombinant production of natural ingredients by acquiring Dutch Isobionics BV and collaborating with Conagen Inc.

Read more

Gut bacterial enzyme keeps inflammation away

An antimicrobial molecule produced by the human microbiota gut may help fight drug-resistant infections.

Read more